Bath & Body Works, Inc. (NYSE:BBWI) affirmed its FY2025 guidance and appointed Daniel Heaf as CEO on Monday.
The company affirmed its adjusted EPS guidance of $3.25 to $3.60 per share versus market estimates of $3.52 per share. The company also affirmed its FY2025 sales outlook of $7.38 billion to $7.53 billion versus expectations of $7.47 billion.
Bath & Body Works shares gained 1.2% to trade at $33.97 on Tuesday.
These analysts made changes to their price targets on Bath & Body Works following the announcement.
- UBS analyst Jay Sole maintained Bath & Body Works with a Neutral and raised the price target from $32 to $36.
- Barclays analyst Adrienne Yih maintained the stock with an Equal-Weight rating and raised the price target from $31 to $35.
- Telsey Advisory Group analyst Dana Telsey maintained Bath & Body Works with an Outperform rating and maintained a $43 price target.
Considering buying BBWI stock? Here’s what analysts think:
Read This Next:
Photo via Shutterstock
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
